Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism. (Q37629269)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

review article

1 reference

title

Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Federica Fulceri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Luigi Murri

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Stefano Ruggieri

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Antonio Paparelli

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

International Review of Neurobiology

12 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

371-398

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens

12 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine-induced behavioral sensitization and its implications for relapse of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Basis of phencyclidine's ability to decrease the synaptosomal accumulation of 3H-catecholamines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Behavioural sensitization in 6-hydroxydopamine lesioned rats involves the dopamine signal transduction: changes in DARPP-32 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Morphological and biochemical evidence that apomorphine rescues striatal dopamine terminals and prevents methamphetamine toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Recognition of a dopamine replacement therapy dependence syndrome in Parkinson's disease: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Modulation of levodopa-induced motor response complications by NMDA antagonists in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Does levodopa aggravate Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Levodopa addiction in idiopathic Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

PET studies and motor complications in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine rapidly decreases vesicular dopamine uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Serial analysis of gene expression in the rat striatum following methamphetamine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA, receptors in the striatopallidal complex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Levodopa therapy: consequences of the nonphysiologic replacement of dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The significance of continuous dopaminergic stimulation in the treatment of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Dual alteration of limbic dopamine D1 receptor-mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Rôle et régulation du récepteur D1 de la dopamine dans le striatum : implications dans les dyskinésies de la maladie de Parkinson

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Where does parkinson disease pathology begin in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Drug-Induced Psychosis Associated with Crystalline Methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Compulsive drug use linked to sensitized ventral striatal dopamine transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

New insights into the mechanism of action of amphetamines

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Species differences in the role of excitatory amino acids in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Striatal dopamine metabolism in monoamine oxidase B-deficient mice: a brain dialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Dose-dependent protective effects of apomorphine against methamphetamine-induced nigrostriatal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine produces neuronal inclusions in the nigrostriatal system and in PC12 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Mechanism of an exaggerated locomotor response to a low-dose challenge of methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Psychotic complications of long-term levodopa treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The nigrostriatal DA pathway and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The role of the locus coeruleus in the development of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Novel aspects of dopamine oxidative metabolism (confounding outcomes take place of certainties).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Regulation of psychostimulant-induced preprodynorphin, c-fos and zif/268 messenger RNA expression in the rat dorsal striatum by mu opioid receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Multiple high doses of methamphetamine increase the number of preproneuropeptide Y mRNA-expressing neurons in the striatum of rat via a dopamine D1 receptor-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

D1 receptor modulation of memory retrieval performance is associated with changes in pCREB and pDARPP-32 in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Mental symptoms in Parkinsonian patients treated with L-dopa.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Continuous and intermittent levodopa differentially affect basal ganglia function

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

L -dopa-induced adverse effects in PD and dopamine transporter gene polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Comparative effects of acute or chronic administration of levodopa to 6-hydroxydopamine-lesioned rats on the expression of glutamic acid decarboxylase in the neostriatum and GABAA receptors subunits in the substantia nigra, pars reticulata

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: a prospective study using single-dose challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Early post-treatment with haloperidol retards induction of methamphetamine sensitization in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Dopamine D1 receptor antagonist SCH 23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Transient calcium and dopamine increase PKA activity and DARPP-32 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine abuse: a perfect storm of complications

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Association between dopamine receptor D1 A-48G polymorphism and methamphetamine abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine-induced sensitization differentially alters pCREB and DeltaFosB throughout the limbic circuit of the mammalian brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Nullifying drug-induced sensitization: behavioral and electrophysiological evaluations of dopaminergic and serotonergic ligands in methamphetamine-sensitized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The NMDA/D1 receptor complex as a new target in drug development.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Why is parkinsonism not a feature of human methamphetamine users?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Immunohistochemical Changes of the Transcription Regulatory Factors in Rat Striatum after Methamphetamine Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Genetic variant of prodynorphin gene is risk factor for methamphetamine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Continuous dopaminergic stimulation: Is it the answer to the motor complications of Levodopa?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Glutamate-mediated striatal dysregulation and the pathogenesis of motor response complications in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Effect of dopamine denervation and dopamine agonist administration on serine phosphorylation of striatal NMDA receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

DeltaFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Gene expression differences in mice divergently selected for methamphetamine sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Synapse formation and plasticity: recent insights from the perspective of the ubiquitin proteasome system

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Endogenous dopamine release after pharmacological challenges in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Ubiquitin-immunoreactive structures in the midbrain of methamphetamine abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Uncoupling protein 2/3 immunoreactivity and the ascending dopaminergic and noradrenergic neuronal systems: relevance for volume transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The opioid agonist morphine decreases the dyskinetic response to dopaminergic agents in parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Opioids and motor complications in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methylphenidate alters vesicular monoamine transport and prevents methamphetamine-induced dopaminergic deficits

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

1 reference

7 January 2021

Punding and dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine-induced choreoathetosis and rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy).

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Continuous dopaminergic stimulation in early and advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Prospective randomized trial of lisuride infusion versus oral levodopa in patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Inhibition of monoamine oxidase by d-methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Changes of behavior and monoamine metabolites in the rat brain after repeated methamphetamine administration: effects of duration of repeated administration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Modulation of dopamine mediated phosphorylation of AMPA receptors by PSD-95 and AKAP79/150.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Pathological gambling: focusing on the addiction, not the activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Role of mu-opioid receptor in modulation of preproenkephalin mRNA expression and opioid and dopamine receptor binding in methamphetamine-sensitized mice

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Monoamine oxidases: certainties and uncertainties

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Inhibition of dopamine synthesis with alpha-methyl-p-tyrosine abolishes the enhancement of methamphetamine-induced extracellular dopamine levels in the amygdala of rats with excitotoxic lesions of the entorhinal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Advanced findings on the molecular mechanisms for behavioral sensitization to psychostimulants

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Priming with L-DOPA differently affects dynorphin and substance P mRNA levels in the striatum of 6-hydroxydopamine-lesioned rats after challenge with dopamine D1-receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

A role for endocannabinoids in the generation of parkinsonism and levodopa-induced dyskinesia in MPTP-lesioned non-human primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Inhibition of methamphetamine self-administration in rats by cannabinoid receptor antagonist AM 251.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Enhancement of dopamine release from striatal slices of rats that were subchronically treated with methamphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Repeated methamphetamine administration alters expression of the NMDA receptor channel epsilon2 subunit and kinesins in the mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Ubiquitin and protein turnover in synapse function

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Roles of dopamine D1 receptors in striatal fos protein induction associated with methamphetamine behavioral sensitization in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The therapeutic potential of monoamine oxidase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: the role of sensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

The role of noradrenergic and dopaminergic hyperactivity in the development of spontaneous recurrence of methamphetamine psychosis and susceptibility to episode recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

An essential role for DeltaFosB in the nucleus accumbens in morphine action

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

c-Fos facilitates the acquisition and extinction of cocaine-induced persistent changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2809%2988013-6

7 January 2021

10.1016/S0074-7742(09)88013-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19897084%20AND%20SRC:MED&resulttype=core&format=json